J Frontier Co.,Ltd. announces an Equity Buyback for 220,000 shares, representing 4.67% for ¥497.42 million.
December 15, 2021 at 12:30 pm IST
Share
J Frontier Co.,Ltd. (TSE:2934) announces a share repurchase program. Under the program, the company will repurchase up to 220,000 shares, representing 4.67% of its issued share capital (excluding treasury stock), for ¥497.42 million. The shares will be repurchased at a price of ¥2,261 per share. The purpose of the program is to improve shareholder profits by improving capital efficiency, implement flexible capital policies such as M&A, and secure excellent human resources by utilizing incentive plans for directors and employees. The program will run until December 16, 2021. As of November 30, 2021, the company had 4,714,000 shares in issue (excluding treasury stock) and no shares in treasury.
J Frontier Co Ltd is a Japan-based company mainly engaged in the electronic commerce sale business for healthcare-related products and pharmaceuticals, the provision of online medication guidance, drug delivery platform SOKUYAKU, as well as the Internet advertising agency business for healthcare-related services. The Company operates through three business segments. The Healthcare Sales segment is engaged in the planning and development of health foods and cosmetics represented by the 328 selection series of fermented hydrogen and mail-order sales. The Medical Care Sales segment is engaged in the operation of dispensing pharmacies, mail-order business of ethical drugs, as well as planning, development and mail-order sales of drugs such as Why Pure series and Chinese herbs. The Health Care Marketing segment is mainly engaged in advertising agency business related to health care products, sales promotion support for health care products, as well as wholesale of in-house products.